Newsletter | September 30, 2021

09.30.21 -- Navigating Bioconjugate Development

 
How Can You Improve Your ADC’s Chance Of Clinical Success?
 

Improving your ADC’s chance of clinical success requires an understanding of what potential obstacles lie ahead and what capabilities and expertise are necessary to overcome them.

ADCs: Groundbreaking Tools In The Fight Against Cancer
 

Despite the potential of ADCs and other bioconjugates, they present a wide range of challenges for drug developers and manufacturers trying to navigate their way to commercial success.

Navigating Bioconjugate Development: A Q&A With Experts
 

Explore the complexity and uncertainty that defines the bioconjugates market and how companies can position themselves to mitigate that uncertainty at every stage of development.

Commercializing A Biotherapeutic: Challenges And Successes
 

Working with a partner that can provide a one-stop shop for bioconjugate development and manufacturing can help to prevent missteps that could threaten your ability to deliver life-saving drugs to patients who need them.

Moving A Bioconjugate Candidate From Clinic To Market
 

Drug developers must successfully navigate a novel drug’s path to market under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.